RenovoRx
NASDAQ: RNXT
$1.29
+0.03
(+2.38%)
as on
RenovoRx Stock Performance
as on November 4, 2026 at 2:15 pm IST
Day's Low
Day's High
$1.24$1.33
3.88%
Downside
3.10%
Upside
52 Week's Low
52 Week's High
$0.70$2.5945.69%
Downside
100.78%
Upside
RenovoRx share price movements today
- Previous Close
- $1.26
- Open
- $1.24
- Volume
- 764.8K
- Market Cap
- $60.0M
- Day's Low - High
- $1.24 - $1.33
- 52 Week Low - High
- $0.70 - $2.59
RenovoRx Historical Returns
- 1 Month Return
- -20.25 %
- 3 Month Return
- + 18.87 %
- 1 Year Return
- + 15.6 %
- 3 Year Return
- + 9.57 %
- 5 Year Return
- -76.8 %
RenovoRx Stock Fundamentals & Key Indicators
Check RenovoRx market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$60.0M
EPS (TTM)
-0.3163
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.2
Industry PE ratio
-3.13
PEG Ratio
-0.23
EBITDA
-12.3M
Revenue (TTM)
2.0M
Profit Margin
84.41%
Return On Equity TTM
-145.63%
RenovoRx vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of RenovoRx with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $60.0M | -76.80% | -4.20 | 84.41% | 0.00% | |
| Neutral | $88.5B | -36.16% | -27.78 | -12.57% | 0.00% | |
| StrongBuy | $141.7B | 192.56% | 32.27 | 86.04% | 0.00% | |
| Buy | $95.5B | 47.41% | 19.76 | 85.77% | 0.40% |
Stock Returns calculator for RenovoRx Stock including INR - Dollar returns
The RenovoRx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
RenovoRx investment value today
Current value as on today
₹1,26,374
Returns
₹26,374
(+26.37%)
Returns from RenovoRx Stock
₹18,349 (+18.35%)
Dollar Impact
₹8,025 (+8.03%)
Analyst Recommendation on RenovoRx Stock
Based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for RenovoRx. Average target price of $7.12
RenovoRx Share Price Target
Get share price movements and forecasts by analysts on RenovoRx.
What analysts predicted
81.88%UPSIDE
Target Price
$7.12
Current Price
$1.29
Analyzed by
2 Analysts
High
$8
Target
$7.12
Low
$3
RenovoRx target price $7.12, a slight upside of 81.88% compared to current price of $1.29. According to 2 analysts rating.
Indian Investors' Interest in RenovoRx Stock
Search interest for RenovoRx Stock has decreased by -80% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
RenovoRx Quarterly Profit & Loss
All numbers in Millions USD
RenovoRx Annual Profit & Loss
All numbers in Millions USD
RenovoRx Quarterly Cash Flow
All numbers in Millions USD
RenovoRx Annual Cash Flow
All numbers in Millions USD
RenovoRx News & Key Events
Today's Timeline - 01 October
Thu, 06:00 PM
-RenovoRx publishes peer-reviewed case series on TAMP platform's effectiveness in treating locally advanced pancreatic cancer.
Insights on RenovoRx
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, RNXT stock has moved up by 21.2%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 829.8% return, outperforming this stock by 806.3%
- NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 184.8% return, outperforming this stock by 175.2%
About RenovoRx
| Organisation | RenovoRx |
| Headquarters | 4546 El Camino Real, Mountain View, CA, 94040, US |
| Industry | Biotechnology |
| CEO | Shaun R. Bagai |
Key Management of RenovoRx
Name | Title |
|---|---|
Dr. Ramtin Agah M.D. | Founder, Executive Chairman & Chief Medical Officer |
Mr. Shaun R. Bagai | CEO, Secretary & Director |
Mr. Ronald B. Kocak CPA, CGMA | VP of Finance & Controller |
Mr. Mark Voll | CFO & Principal Accounting Officer |
Mr. Tom Kelly | Vice President of Quality & Operations |
Mr. Phil Stocton | Vice President of Sales & Market Development |
Ms. Leesa Gentry | Chief Clinical Officer |
FAQs
What is RenovoRx share price today?
RenovoRx share price today is $1.29 as on at the close of the market. RenovoRx share today touched a day high of $1.33 and a low of $1.24.
What is the 52 week high and 52 week low for RenovoRx share?
RenovoRx share touched a 52 week high of $2.59 on and a 52 week low of $0.70 on . RenovoRx stock price today i.e. is closed at $1.29,which is 50.19% down from its 52 week high and 84.13% up from its 52 week low.
What is RenovoRx's market capitalisation today?
RenovoRx market capitalisation is $0.00T as on .
How to invest in RenovoRx Stock (RNXT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for RenovoRx on INDmoney app. Click on Buy button.
What is the minimum amount required to buy RenovoRx Stock (RNXT) from India?
Indian investors can start investing in RenovoRx (RNXT) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.40 in RenovoRx stock (as per the Rupee-Dollar exchange rate as on ).
Based on RenovoRx share’s latest price of $1.29 as on November 4, 2026 at 8:45 am IST, you will get 7.7519 shares of RenovoRx. Learn more about
fractional shares .
What are the returns that RenovoRx has given to Indian investors in the last 5 years?
RenovoRx stock has given -76.8% share price returns and 27.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?